JP2002535407A5 - - Google Patents

Download PDF

Info

Publication number
JP2002535407A5
JP2002535407A5 JP2000596008A JP2000596008A JP2002535407A5 JP 2002535407 A5 JP2002535407 A5 JP 2002535407A5 JP 2000596008 A JP2000596008 A JP 2000596008A JP 2000596008 A JP2000596008 A JP 2000596008A JP 2002535407 A5 JP2002535407 A5 JP 2002535407A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
formula
acceptable salt
triazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000596008A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002535407A (ja
Filing date
Publication date
Priority claimed from GBGB9901744.4A external-priority patent/GB9901744D0/en
Priority claimed from GBGB9901743.6A external-priority patent/GB9901743D0/en
Priority claimed from GBGB9912429.9A external-priority patent/GB9912429D0/en
Application filed filed Critical
Priority claimed from PCT/GB2000/000183 external-priority patent/WO2000044752A1/en
Publication of JP2002535407A publication Critical patent/JP2002535407A/ja
Publication of JP2002535407A5 publication Critical patent/JP2002535407A5/ja
Withdrawn legal-status Critical Current

Links

JP2000596008A 1999-01-27 2000-01-19 Gaba受容体のリガンドとしてのトリアゾロピリダジン誘導体 Withdrawn JP2002535407A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9901744.4A GB9901744D0 (en) 1999-01-27 1999-01-27 Therapeutic agents
GBGB9901743.6A GB9901743D0 (en) 1999-01-27 1999-01-27 Therapeutic agents
GB9901744.4 1999-05-27
GB9901743.6 1999-05-27
GB9912429.9 1999-05-27
GBGB9912429.9A GB9912429D0 (en) 1999-05-27 1999-05-27 Therapeutic agents
PCT/GB2000/000183 WO2000044752A1 (en) 1999-01-27 2000-01-19 Triazolo-pyridazine derivatives as ligands for gaba receptors

Publications (2)

Publication Number Publication Date
JP2002535407A JP2002535407A (ja) 2002-10-22
JP2002535407A5 true JP2002535407A5 (cg-RX-API-DMAC7.html) 2007-03-08

Family

ID=27269629

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000596008A Withdrawn JP2002535407A (ja) 1999-01-27 2000-01-19 Gaba受容体のリガンドとしてのトリアゾロピリダジン誘導体

Country Status (9)

Country Link
US (2) US6500828B1 (cg-RX-API-DMAC7.html)
EP (1) EP1149102B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002535407A (cg-RX-API-DMAC7.html)
AT (1) ATE284403T1 (cg-RX-API-DMAC7.html)
AU (1) AU772947B2 (cg-RX-API-DMAC7.html)
CA (1) CA2359008C (cg-RX-API-DMAC7.html)
DE (1) DE60016566T2 (cg-RX-API-DMAC7.html)
ES (1) ES2232416T3 (cg-RX-API-DMAC7.html)
WO (1) WO2000044752A1 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000564D0 (en) 2000-01-11 2000-03-01 Merck Sharp & Dohme Therapeutic agents
WO2002083139A1 (en) 2001-04-10 2002-10-24 Merck & Co., Inc. Inhibitors of akt activity
US6960584B2 (en) 2001-04-10 2005-11-01 Merck & Co., Inc. Inhibitors of Akt activity
WO2002083140A1 (en) 2001-04-10 2002-10-24 Merck & Co., Inc. Inhibitors of akt activity
DE60315876T2 (de) * 2002-11-28 2008-05-21 Neurosearch A/S Verfahren zum screening für verbindungen mit sedativer oder anxiolytischer potenz
WO2006061428A2 (en) * 2004-12-10 2006-06-15 Universität Zürich Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
HRP20140195T1 (hr) * 2008-08-29 2014-04-11 Concert Pharmaceuticals Inc. Supstituirani derivati triazolopiridazina
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2454259A1 (en) 2009-06-23 2012-05-23 Concert Pharmaceuticals Inc. Deuterium-modified triazolo-pyridazine derivatives as gaba-a receptor modulators
US8278460B2 (en) 2009-10-15 2012-10-02 Concert Pharmaceuticals, Inc. Substituted benzimidazoles
US20150099753A1 (en) * 2012-05-11 2015-04-09 Concert Pharmaceuticals Inc. Form 5 polymorph of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine
JP2015516440A (ja) * 2012-05-11 2015-06-11 コンサート ファーマシューティカルズ インコーポレイテッド 7−(tert−ブチル−d9)−3−(2,5−ジフルオロフェニル)−6−((1−メチル−1H−1,2,4−トリアゾール−5−イル)メトキシ)−[1,2,4]トリアゾロ[4,3−b]ピリダジンの2型多形
WO2013170241A1 (en) * 2012-05-11 2013-11-14 Concert Pharmaceuticals, Inc. Polymorphs of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolol[4,3b]pyridazine
WO2015095549A1 (en) * 2013-12-18 2015-06-25 Concert Pharmaceuticals, Inc. Dosage regimen for gabaa receptor subtype selective drug
HUE060943T2 (hu) * 2018-09-13 2023-04-28 Saniona As A gaba A receptor ligandum
AU2023258030A1 (en) * 2022-04-20 2024-10-17 Engrail Therapeutics, Inc. Gabaa receptor modulator salts, particles, and uses thereof
CN115837022B (zh) * 2023-02-20 2023-04-25 中山大学附属第八医院(深圳福田) 1,2,4三唑并4,3-b哒嗪衍生物在制备抗衰老药物中的应用
AU2024411621A1 (en) 2023-12-27 2026-06-18 Saniona A/S A gabaa receptor ligand and the use thereof in medicine, in particular in the treatment of epilepsy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0915875B1 (en) * 1996-07-25 2003-04-09 MERCK SHARP & DOHME LTD. Substituted triazolo-pyridazine derivatives as ligands for gaba receptors

Similar Documents

Publication Publication Date Title
JP2004531563A5 (cg-RX-API-DMAC7.html)
RU2000104863A (ru) Производные 1,2,4-триазоло[4,3-b]пиридо[3,2-d]пиридазина и фармацевтические композиции, содержащие их
JP2006513268A5 (ja) アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体
EP2152712B1 (en) Amino-heterocyclic compounds
RU2000113729A (ru) Гетероциклические соединения для ингибирования секреции желудочной кислоты, способы их получения и их фармацевтические компоозиции
JP2004514663A5 (cg-RX-API-DMAC7.html)
JP2003128673A5 (cg-RX-API-DMAC7.html)
WO2000042026B1 (en) Non-peptide glp-1 agonists
JP2013532652A5 (cg-RX-API-DMAC7.html)
JP2003516363A (ja) 勃起機能不全の処置のためのホスホジエステラーゼインヒビターの経粘膜投与
RU2006144075A (ru) ДИФЕНИЛИМИДАЗОПИРИМИДИН И -ИМИДАЗОЛАМИНЫ КАК ИНГИБИТОРЫ β-СЕКРЕТАЗЫ
JP2003531210A5 (cg-RX-API-DMAC7.html)
JP2004528334A5 (cg-RX-API-DMAC7.html)
JP2005047930A5 (cg-RX-API-DMAC7.html)
JP2008518890A5 (cg-RX-API-DMAC7.html)
JP2002536359A5 (cg-RX-API-DMAC7.html)
JP2008509187A5 (cg-RX-API-DMAC7.html)
JP2007507494A5 (cg-RX-API-DMAC7.html)
JP2005526836A5 (cg-RX-API-DMAC7.html)
JP2008001722A5 (cg-RX-API-DMAC7.html)
JP2002518502A5 (cg-RX-API-DMAC7.html)
JP2003507479A5 (cg-RX-API-DMAC7.html)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2004517843A5 (cg-RX-API-DMAC7.html)
IL158572A (en) Imidazo [1,5-a] pyrimido [5,4-d] benzazepine derivatives as gaba a receptor modulators